Treatment options in first-line metastatic kidney cancer
Over the past 10 years or so, the use of [...]
Comparison of cabozantinib with axitinib as second-line treatment for metastatic kidney cancer
To date, there have not been any studies that have [...]
Expert interview about cancer vaccines
In this very interesting interview from the Friends of Renal [...]
New PET imaging agent for kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
Factors affecting outcomes after nephrectomy for metastatic kidney cancer
Nephrectomy is surgery to remove all or part of a [...]
New cancer vaccine in development
A new vaccine is being heralded as a 'game changer’ [...]
Lenvatinib plus everolimus for patients with metastatic kidney cancer
The treatment of heavily pretreated patients with metastatic kidney cancer [...]
Adjuvant pembrolizumab prolongs overall survival for kidney cancer patients
Surgery (partial or radical nephrectomy) is the standard of care [...]
CAR T cell immunotherapy shows promise for patients with kidney cancer
Chimeric antigen receptor (CAR) T cell therapy is a type [...]
Real world data on the use of cabozantinib plus immunotherapy in the second line
A recent study looked at the use of a combination [...]
